Skip to main content

Table 1 Management recommendations to improve care of ED patients with atrial fibrillation and flutter

From: Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O’CAFÉ trial)

Major recommendations in electronic clinical decision support applicationa

Rationale for recommendation

1. Sustained rate reduction

Administer long-acting rate-reducing medications early in the ED encounter, either in addition to or in lieu of standard intravenous bolus medications

Medications with sustained effect on rapid ventricular response have been central to multifaceted ED interventions associated with reduced hospitalization of patients with isolated AF or atrial flutter [26, 27].

2. Effective cardioversion

 2A. Electrical

Start with maximal joules and consider manual pressure augmentation, especially for obese patients

These measures improve first-shock success and may reduce sedation duration and risk [13, 39,40,41].

 2B. Pharmacologic

Consider efficiency in addition to effectiveness, safety, and ease of administration when selecting medications

For example, medications with a shorter time to effect, e.g., intravenous procainamide [42] (median 30–40 min), facilitate ED operational efficiencies, unlike intravenous amiodarone, which does not distinguish itself from placebo for 6–8 h [43].

3. Stroke prevention

A. Identify patients at risk using auto-populating validated scoring system

Stroke risk stratification is the essential preparatory step for any subsequent stroke prevention action [13, 14, 29, 33].

B. Print risk-specific handout for eligible patients and review with patient and family at bedside

The handout helps initiate a shared decision-making conversation on stroke prevention [44] that can continue with outpatient physicians following discharge to home

C1. Initiate outpatient anticoagulation at the time of ED discharge to home

Oral anticoagulation with DOACs or warfarin significantly reduces ischemic stroke and death in patients with AF or atrial flutter. Prescription on ED discharge can be associated with higher long-term use than when prescribing is left to post-discharge outpatient care [45, 46].

C2. Or electronically consult the Anticoagulation Management Service to request they contact patients who want to learn more about stroke prevention before initiating anticoagulation

Following discharge to home, anticoagulation pharmacists can call eligible patients to provide in-depth education on benefits and risks of anticoagulation for stroke prevention [47, 48].

4. Timely follow-up

a. Encourage or request close follow-up (< 7d) with outpatient physicians

Transferring care to outpatient physicians who can oversee longitudinal care of AF and atrial flutter and related conditions is key to long-term management success [14]. Moreover, follow-up of these patients within a week of discharge has been associated with a reduction in the rate of death and hospitalization within 1 year [49].

  1. AF Atrial fibrillation, DOAC Direct oral anticoagulant, ED Emergency department
  2. aRISTRA-AF also reminds physicians to inquire of their AF and atrial flutter patients about two dietary triggers: cold drink/food and alcohol (more below) [50, 51]